Check your coverage See whether your GLP-1 medication is covered by your insurance plan
FDA has accepted the NDA for an oral formulation of Novo Nordisk A/Ss Wegovy (semaglutide) in treating obesity
GLP-1 Progress Tracker App Track weight trends, progress photos, Journey Cards, dose context, food, side effects, protein, water, and medication-level context in one GLP-1 app
By helping the body use fat more efficiently, L-Carnitine promotes consistent progress and supports healthier metabolic function
While increased gastrointestinal side effects were noted, the overall tolerability appears acceptable
This mechanistic insight has prompted the exploration of ferroptosis as a therapeutic target, given its potential contribution to dopaminergic neuronal loss and disease progression